Open Access Open Access  Restricted Access Subscription Access

Understanding the Connection between Drugs and Lobular Pneumonia

Muralinath E., Singh H. S., Vijay Digamber D, Shraddha D., Lalit Kumar S., Kalyan C., Archana Jain, Guruprasad M.

Abstract


Lobular pneumonia, also termed as broncho pneumonia, is a type of pneumonia that influences multiple areas of the lungs. Bacterial and viral infections result in lobular pneumonia. Corticosteroids or immuno suppressive agents may enhance the risk of lobular pneumonia. In some cases, Non_steroidal anti_ inflammatory drugs (NSAID,s) can result in drug_ induced pneumonia, along with the lobular pneumonia subtype. Antibiotics sometimes can result in pneumonia. Benzodiazepines (sedative drug) can enhance the risk of aspiration pneumonia. Immunization against preventable respiratory infections, such as influenza and pneumonia, is critical for individuals consuming medications that comprise their immune system. Finally it is concluded that while lobular pneumonia is often attributed to infections agents, it is responsible for recognizing the role that a very few medications can play in its development.


Full Text:

PDF

References


Luna, C. M., Pulido, L., Niederman, M. S., Casey, A., Burgos, D., Leiva Agüero, S. D., ... & Famiglietti, A. (2018). Decreased relative risk of pneumococcal pneumonia during the last decade, a nested case-control study. Pneumonia, 10, 1-8.

Cillóniz, C., Dominedo, C., Garcia-Vidal, C., & Torres, A. (2018). Community-acquired pneumonia as an emergency condition. Current opinion in critical care, 24(6), 531-539.

Shoji, H., Vázquez-Sánchez, D. A., Gonzalez-Diaz, A., Cubero, M., Tubau, F., Santos, S., ... & Ardanuy, C. (2018). Overview of pneumococcal serotypes and genotypes causing diseases in patients with chronic obstructive pulmonary disease in a Spanish hospital between 2013 and 2016. Infection and Drug Resistance, 1387-1400.

Regev-Yochay, G., Chowers, M., Chazan, B., Gonzalez, E., Gray, S., Zhang, Z., & Pride, M. (2018). Distribution of 13-Valent pneumococcal conjugate vaccine serotype streptococcus pneumoniae in adults 50 Years and Older presenting with community-acquired pneumonia in Israel. Human Vaccines & Immunotherapeutics, 14(10), 2527-2532.

Quah, J., Jiang, B., Tan, P. C., Siau, C., & Tan, T. Y. (2018). Impact of microbial Aetiology on mortality in severe community-acquired pneumonia. BMC infectious diseases, 18(1), 1-9.

Ghaffar, F., Friedland, I. R., & GEORGE H MCCRACKEN, J. R. (1999). Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae. The Pediatric infectious disease journal, 18(7), 638-646.

Alqahtani, A. S., Tashani, M., Ridda, I., Gamil, A., Booy, R., & Rashid, H. (2018). Burden of clinical infections due to S. pneumoniae during Hajj: A systematic review. Vaccine, 36(30), 4440-4446.

Wahl, B., O'Brien, K. L., Greenbaum, A., Majumder, A., Liu, L., Chu, Y., ... & Knoll, M. D. (2018). Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15. The Lancet Global Health, 6(7), e744-e757.


Refbacks

  • There are currently no refbacks.